Skip to content
WeighLab
Grade C

MEDVi Review: Price, Pros & Cons

By The WeighLab Bench, Tools & Data Desk

MEDVi charges $179 for the first month of compounded semaglutide and $299 for every refill after, with the visit and medication in one price; brand Wegovy and Zepbound carry a $99 membership plus the drug's cost.

Visit MEDVi Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. See our disclosure.
Semaglutide
$299/moMonth-to-month refill price; first month $179, compounded
Tirzepatide
Not disclosed
Coverage
Not published
Brand-name
Yes

Semaglutide · modeled / year

$3,588

The Index scorecard

MEDVi scored on our six Cost-Efficiency Index factors. See the methodology.

Normalized Cost/Month50/100
Price Transparency92/100
Nationwide Access24/100
Formulation Options77/100
Clinical Oversight70/100
Contract Flexibility67/100

Where the value is

  • The FAQ states both numbers plainly: $179 for the first month and refills locked in at $299, covering the provider review, the medication and shipping
  • No contract; you can cancel at any time by email or through the patient portal chat
  • Names its partner pharmacies (Triad Rx, RedRock Pharmacy and Beaker Pharmacy & Compounding) and the medical groups behind its providers
  • Offers compounded GLP-1 tablets from $249 and brand Wegovy (injection and pill) and Zepbound alongside compounded injections

The tradeoffs

  • The $179 headline is a first-month "FALL Sale" price; every refill after that is $299
  • Cancellation must reach support at least 72 hours before your next billing date, and monthly charges are never refunded once the month has started
  • No state list is published; the terms say to contact customer service to find out whether your state is served
  • Tirzepatide has no published price, and the brand options show only "$99 Membership + Medication Cost" with no drug price
  • The footer says some site content may be AI-generated and that people in ads may be actors or models
  • Compounded semaglutide is not an FDA-approved product
  • FDA issued MEDVi, LLC dba MEDVi a warning letter in February 2026; the letter is public in FDA's warning-letter database

The bottom line

Best for: Shoppers who want compounded semaglutide with no contract and are budgeting on the $299 refill price, not the first-month sale price. MEDVi charges $179 for the first month of compounded semaglutide and $299 for every refill after, with the visit and medication in one price; brand Wegovy and Zepbound carry a $99 membership plus the drug's cost.

For comparison, read our review of CoreAge Rx, one of our partners. Partners are listed first on our leaderboard; every provider is scored on the same six factors.

Other programs to compare with MEDVi

These are partners: we may earn a commission if you sign up, at no cost to you.

  • EmbodyPartner

    Semaglutide from $79/mo · tirzepatide from $129/mo

    Embody sells compounded semaglutide from $79 a month and tirzepatide from $129, marked as sale prices, with prescribers from the OpenLoop Health network.

  • Enhance MDPartner

    Semaglutide from $212/mo · tirzepatide from $280/mo

    Enhance MD charges $212 a month for compounded semaglutide and $280 for tirzepatide at every dose, with lab work every six months included; the first month is $100 less.

  • HealthRXPartner

    Semaglutide from $190/mo · tirzepatide from $239/mo

    HealthRX charges $190 a month for compounded semaglutide and $239 for tirzepatide month to month; the $99 and $179 it advertises are prepaid twelve-month prices.

Compare with other providers

The providers whose Cost-Efficiency Index scores sit closest to MEDVi's. See the alternatives to MEDVi.

The 22 programs nearest this one

Pricing, states and verification reflect MEDVi's public disclosures at last review; the Cost-Efficiency Index is our editorial judgment per the methodology. Prices change — confirm on MEDVi's site. Not medical advice; see our disclosure.

← Back to the value leaderboard